Immutep Limited - American Depositary Shares (IMMP) analyst actions
Rating and price-target actions on IMMP in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the IMMP overview →
3 measured IMMP analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ImmunityBio, Inc. (IMMP) And Encourages Stockholders to Reach Out | Press release | +1.45% | +2.09% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Immutep Limited (IMMP) And Encourages Stockholders to Reach Out | Press release | -0.12% | -0.15% | |
| Immutep Announces Initiation of TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer | Press release | -2.75% | -2.75% |
Keep exploring
More IMMP: earnings → · SEC filings → · IMMP overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| VolitionRX Limited (VNRX) | 498 | -0.05% | 41% |
| ANI Pharmaceuticals, Inc. (ANIP) | 496 | -0.05% | 46% |
| FOAMIX PHARMACEUTICALS LTD (FOMX) | 493 | -0.29% | 41% |
| AzurRx BioPharma, Inc. (AZRX) | 492 | -0.24% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.